Nutex Health shares surge 17.13% after-hours as board extends $25M share repurchase program to boost shareholder value and offset dilution.

Nutex Health (NASDAQ: NUTX) surged 17.13% in after-hours trading following the announcement that its board extended a $25 million share repurchase program through March 31, 2026. The extension, first authorized in August 2025, aims to boost shareholder value and offset dilution from stock compensation tied to new hospital developments. The program will be executed under Rule 10b-18 and a Rule 10b5-1 trading plan, effective December 4, 2025, signaling disciplined capital allocation. The move underscores management’s confidence in the company’s financial position, supported by strong cash flow and recent quarterly earnings growth, while addressing potential share dilution. The after-hours rally aligns with the perceived positive impact of the buyback extension on equity value.